Medanta’s Financials Shine: Highest Ever Quarterly EBITDA in Q1 FY2026
Global Health Limited (NSE: Medanta, BSE: 543654), one of the largest private multi-specialty tertiary care providers in North and East India, today announced its unaudited consolidated financial results for the quarter ended June 30, 2025, reporting its highest-ever Q1 performance.
Total income rose 19.1% year-on-year to ₹10,513 million, EBITDA increased 22.6% to ₹2,553 million, and Profit After Tax surged 49.6% to ₹1,590 million, with PAT margins improving to 15.1%. Key growth drivers included a 13.3% increase in occupied bed days, a 4% rise in ARPOB to ₹66,584, and double-digit growth in in-patient and out-patient volumes. Mature hospitals generated ₹7,006 million in revenue, while developing hospitals grew 35.9% to ₹3,219 million. International patient revenue climbed 33.8% to ₹636...










